Risks associated with transfusion of cellular blood components in Canada.
Comprehensive article on possible adverse reactions and risks of blood transfusion (43 pages). – Volker Kretschmer
US NAT yield: where are we after 2 years?
Discussion of very recent literature, calculation of current risk of transfusion transmitted viral infections after introduction of NAT-HCV and NAT-HIV. Determination of cost/benefit of introduction of NAT. Conclusive statement that […]